South Korean and U.S. soldiers conducted joint special strike drills this week as part of an ongoing major allied exercise, ...

Biopharma deal activity climbed in early 2025, reaching $37.38 billion in the first two months, up from $35.66 billion a year ...

Drones could address the biggest challenges in these fights, like a lack of situational awareness and communications problems ...

The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the ...

Canada has announced new sanctions on seven individuals and three entities associated with the ongoing conflict in Sudan. In a statement today, Canada's Minister of Foreign Affairs, Mélanie Joly, ...

In the past, fielding technologies to warfighters has followed a structured lather, rinse, repeat routine. The demand signal for a capability comes ...

A new study by the U.S. Army Research Institute reveals the science behind who makes the cut to become an elite Special ...

LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK ... not consider the pharmaceutical industry to be all that special with respect to other verticals, including technology ...

Oxford, United Kingdom – 26 February 2025 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying medicines against highly validated target ecosystems such ...

But it is only at the higher energies explored in particle collisions at CERN and other laboratories that the electromagnetic and weak forces begin to act on equal terms. Will the unification of other ...